Sphera Health

Sphera Health is a joint venture between Arkin Capital and Sphera Funds Management based in Tel Aviv, structured as a long/short equity hedge fund focused on clinical-stage biopharma scale-ups. The hedge fund structure is unusual for a healthcare directory entry and means the firm participates in both private and public market positions with mark-to-market discipline rather than pure venture portfolio construction. Founders should understand they are dealing with an investment vehicle that lives partly in public market dynamics.

The stage focus is Growth, with check sizes between $5 million and $25 million. Sub-verticals are biotech and pharma. The record does not list specific portfolio companies. Geographic activity is concentrated in Israel and likely includes US-listed Israeli biotechs given the hedge fund structure.

For founders, the practical takeaway is that Sphera is a fit only for clinical-stage therapeutic assets with credible paths to public markets or near-term commercial inflection. Pure healthcare AI software, early platform plays, or pre-clinical assets without an enterprise-style asset story will not fit. Founders should be ready to discuss capital markets context, comparable public companies, and a path to an IPO or strategic exit rather than just venture milestones. The hedge fund structure also implies a different governance posture than a typical VC, with potentially less hands-on operational involvement and more financial-market sophistication.